EPCT-05. A PHASE 1/2 STUDY OF AVAPRITINIB FOR KIT- OR PDGFRA-MUTANT PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS

por Chi, Susan, Hsieh, Antony, Foley, Megan, Shi, Hongliang, Swamy, Preethi, Rodstrom, Jill, Rudoltz, Marc
Publicado 2021

TRLS-10. ROVER: A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING

por Koschmann, Carl, Hoffman, Lindsey M, Kramm, Christof M, Plant-Fox, Ashley, Abdelbaki, Mohamed S, Bui, Ashley, Casanova, Michela, Morgenstern, Daniel A, Swamy, Preethi, Shi, Hongliang, Hong, Janet, Rinne, Mikael L, Chi, Susan N
Publicado 2023